381 related articles for article (PubMed ID: 7537534)
21. Mitogenic stimulation of T cells reveals differing contributions for B7-1 (CD80) and B7-2 (CD86) costimulation.
Perrin PJ; Davis TA; Smoot DS; Abe R; June CH; Lee KP
Immunology; 1997 Apr; 90(4):534-42. PubMed ID: 9176106
[TBL] [Abstract][Full Text] [Related]
22. Activation of human peripheral blood dendritic cells induces the CD86 co-stimulatory molecule.
McLellan AD; Starling GC; Williams LA; Hock BD; Hart DN
Eur J Immunol; 1995 Jul; 25(7):2064-8. PubMed ID: 7542604
[TBL] [Abstract][Full Text] [Related]
23. Prevention of primary T-cell responses by immunotoxins directed against CD80 and CD86.
Otten HG; Vooijs WC; van der Gouw AP; de Boer M; de Gast GC
Transplant Proc; 1997; 29(1-2):1034-5. PubMed ID: 9123185
[No Abstract] [Full Text] [Related]
24. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
25. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.
Kruger M; Van Gool S; Peng XH; Coorevits L; Casteels-Van Daele M; Ceuppens JL
Immunology; 1996 May; 88(1):49-54. PubMed ID: 8707349
[TBL] [Abstract][Full Text] [Related]
26. Blocking CD40 - CD154 and CD80/CD86 - CD28 interactions during primary allogeneic stimulation results in T cell anergy and high IL-10 production.
Van Gool SW; Vermeiren J; Rafiq K; Lorr K; de Boer M; Ceuppens JL
Eur J Immunol; 1999 Aug; 29(8):2367-75. PubMed ID: 10458748
[TBL] [Abstract][Full Text] [Related]
27. Differential modulation of B7-1 and B7-2 isoform expression on human monocytes by cytokines which influence the development of T helper cell phenotype.
Creery WD; Diaz-Mitoma F; Filion L; Kumar A
Eur J Immunol; 1996 Jun; 26(6):1273-7. PubMed ID: 8647204
[TBL] [Abstract][Full Text] [Related]
28. B7+ T cells in myeloma: an acquired marker of prior chronic antigen presentation.
Brown R; Murray A; Pope B; Sze D; Gibson J; Ho PJ; Joshua D
Leuk Lymphoma; 2004 Feb; 45(2):363-71. PubMed ID: 15101725
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
Makrigiannis AP; Musgrave BL; Hoskin DW
J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 12 synergizes with B7/CD28 interaction in inducing efficient proliferation and cytokine production of human T cells.
Kubin M; Kamoun M; Trinchieri G
J Exp Med; 1994 Jul; 180(1):211-22. PubMed ID: 7516408
[TBL] [Abstract][Full Text] [Related]
31. CD80, CD86 and CD40 provide accessory signals in a multiple-step T-cell activation model.
Van Gool SW; Vandenberghe P; de Boer M; Ceuppens JL
Immunol Rev; 1996 Oct; 153():47-83. PubMed ID: 9010719
[TBL] [Abstract][Full Text] [Related]
32. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
[TBL] [Abstract][Full Text] [Related]
33. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
[TBL] [Abstract][Full Text] [Related]
34. Lack of B7-1/BB1 and B7-2/B70 expression on thyrocytes of patients with Graves' disease. Delivery of costimulatory signals from bystander professional antigen-presenting cells.
Matsuoka N; Eguchi K; Kawakami A; Tsuboi M; Nakamura H; Kimura H; Ishikawa N; Ito K; Nagataki S
J Clin Endocrinol Metab; 1996 Nov; 81(11):4137-43. PubMed ID: 8923872
[TBL] [Abstract][Full Text] [Related]
35. B7-2 (CD86) is essential for the development of IL-4-producing T cells.
Ranger AM; Das MP; Kuchroo VK; Glimcher LH
Int Immunol; 1996 Oct; 8(10):1549-60. PubMed ID: 8921434
[TBL] [Abstract][Full Text] [Related]
36. Low-dose UVB radiation perturbs the functional expression of B7.1 and B7.2 co-stimulatory molecules on human Langerhans cells.
Weiss JM; Renkl AC; Denfeld RW; de Roche R; Spitzlei M; Schöpf E; Simon JC
Eur J Immunol; 1995 Oct; 25(10):2858-62. PubMed ID: 7589083
[TBL] [Abstract][Full Text] [Related]
37. Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.
Tan P; Anasetti C; Hansen JA; Melrose J; Brunvand M; Bradshaw J; Ledbetter JA; Linsley PS
J Exp Med; 1993 Jan; 177(1):165-73. PubMed ID: 7678111
[TBL] [Abstract][Full Text] [Related]
38. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells.
Moosig F; Csernok E; Wang G; Gross WL
Clin Exp Immunol; 1998 Oct; 114(1):113-8. PubMed ID: 9764612
[TBL] [Abstract][Full Text] [Related]
39. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
[TBL] [Abstract][Full Text] [Related]
40. B7 expression and antigen presentation by human brain endothelial cells: requirement for proinflammatory cytokines.
Prat A; Biernacki K; Becher B; Antel JP
J Neuropathol Exp Neurol; 2000 Feb; 59(2):129-36. PubMed ID: 10749102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]